T. Evans

TACE 2: A randomized placebo-controlled, double-blinded, phase III trial evaluating sorafenib in combination with transarterial chemoembolisation (TACE) in patients with unresectable hepatocellular carcinoma (HCC).

D. Stocken, T. Meyer, P. Johnson, 2012 .

CheckMate-032: Phase I/II, open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (GC).

P. Ascierto, P. Sharma, P. Ott, 2016 .

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

J. Machiels, T. Meyer, S. Topalian, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.